BC is classified into various molecular subtypes based on genetic characteristics and immunophenotypic features such as protein expression, primarily based on biological and clinicopathological features as luminal A, luminal B, HER2-enriched and basal-like or triple-negative BC (TNBC) [4]. Here, ERBB2 is linked to breast cancer.